Functional Outcome of Mesenchymal Stem Cells Vs. Hyaluronic Acid in Knee Osteoarthritis Kellgren-Lawrence Grade I-III At 6-and 12-Months Follow-Up: A Meta-Analysis

Background: Osteoarthritis (OA) is a degenerative synovial joint disease with progressive pain and deformity. Stem cell therapy, especially mesenchymal stem cells (MSCs), has revolutionized the treatment of knee OA. However, clinical evidence for MSCs in the treatment of knee OA is insufficient. The...

Full description

Saved in:
Bibliographic Details
Main Authors: I Gusti Ngurah Wien Aryana, Febyan, Shianita Limena
Format: Article
Language:English
Published: Universitas Airlangga 2023-10-01
Series:Journal Orthopaedi and Traumatology Surabaya
Subjects:
Online Access:https://e-journal.unair.ac.id/JOINTS/article/view/48410
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856518400835584
author I Gusti Ngurah Wien Aryana
Febyan
Shianita Limena
author_facet I Gusti Ngurah Wien Aryana
Febyan
Shianita Limena
author_sort I Gusti Ngurah Wien Aryana
collection DOAJ
description Background: Osteoarthritis (OA) is a degenerative synovial joint disease with progressive pain and deformity. Stem cell therapy, especially mesenchymal stem cells (MSCs), has revolutionized the treatment of knee OA. However, clinical evidence for MSCs in the treatment of knee OA is insufficient. The primary objective of this research is to offer substantiation and recommendations for advancing and utilizing MSC therapy in clinical settings, in contrast to the use of hyaluronic acid (HA) as the standard control group. Methods: This study was a meta-analysis conducted through a search for relevant scientific reports in PubMed, Embase, and Google Scholar, using some keywords such as "mesenchymal stem cell," "hyaluronic acid," and "osteoarthritis." Results: Mesenchymal stem cells showed promising results on a clinical basis. Among five included studies of 139 patients with knee osteoarthritis consisting of 70 patients treated with MSC and 69 patients treated with HA, mesenchymal stem cells provide significant short-term pain relief at 6- (I2=34%; SMD=-0.58 95% CI, -1.09 to -0.07; p=0.02) and 12-months follow-up (I2=28%; SMD=-0.79 95% CI, -1.22 to -0.37; p=0.0003), with relative clinical improvement. The highly differentiated MSC aids in tissue repair, regulation of immune response, and anti-inflammatory effect on knee osteoarthritis, including the chondrogenesis mechanism. Conclusion: Mesenchymal stem cell therapy has shown effectiveness compared to hyaluronic acid injection for knee osteoarthritis, providing pain relief and improved functional outcomes on short-term intervals up to 12 months follow-up. Mesenchymal stem cells display some chondroprotective effects requiring further research and development.
format Article
id doaj-art-a53bc18ba9f04720817873ced72a5e36
institution Kabale University
issn 2722-712X
2460-8742
language English
publishDate 2023-10-01
publisher Universitas Airlangga
record_format Article
series Journal Orthopaedi and Traumatology Surabaya
spelling doaj-art-a53bc18ba9f04720817873ced72a5e362025-02-12T07:27:30ZengUniversitas AirlanggaJournal Orthopaedi and Traumatology Surabaya2722-712X2460-87422023-10-01122667610.20473/joints.v12i2.2023.66-7646498Functional Outcome of Mesenchymal Stem Cells Vs. Hyaluronic Acid in Knee Osteoarthritis Kellgren-Lawrence Grade I-III At 6-and 12-Months Follow-Up: A Meta-AnalysisI Gusti Ngurah Wien Aryana0https://orcid.org/0000-0001-6221-4387Febyan1https://orcid.org/0000-0001-9055-0361Shianita Limena2https://orcid.org/0000-0002-4914-3382Department of Orthopaedic & Traumatology, Prof Ngoerah General Hospital, Faculty of Medicine, Universitas Udayana, Denpasar, IndonesiaResident of Orthopaedic & Traumatology, Prof Ngoerah General Hospital, Faculty of Medicine, Universitas Udayana, Denpasar, IndonesiaResident of Orthopaedic & Traumatology, Prof Ngoerah General Hospital, Faculty of Medicine, Universitas Udayana, Denpasar, IndonesiaBackground: Osteoarthritis (OA) is a degenerative synovial joint disease with progressive pain and deformity. Stem cell therapy, especially mesenchymal stem cells (MSCs), has revolutionized the treatment of knee OA. However, clinical evidence for MSCs in the treatment of knee OA is insufficient. The primary objective of this research is to offer substantiation and recommendations for advancing and utilizing MSC therapy in clinical settings, in contrast to the use of hyaluronic acid (HA) as the standard control group. Methods: This study was a meta-analysis conducted through a search for relevant scientific reports in PubMed, Embase, and Google Scholar, using some keywords such as "mesenchymal stem cell," "hyaluronic acid," and "osteoarthritis." Results: Mesenchymal stem cells showed promising results on a clinical basis. Among five included studies of 139 patients with knee osteoarthritis consisting of 70 patients treated with MSC and 69 patients treated with HA, mesenchymal stem cells provide significant short-term pain relief at 6- (I2=34%; SMD=-0.58 95% CI, -1.09 to -0.07; p=0.02) and 12-months follow-up (I2=28%; SMD=-0.79 95% CI, -1.22 to -0.37; p=0.0003), with relative clinical improvement. The highly differentiated MSC aids in tissue repair, regulation of immune response, and anti-inflammatory effect on knee osteoarthritis, including the chondrogenesis mechanism. Conclusion: Mesenchymal stem cell therapy has shown effectiveness compared to hyaluronic acid injection for knee osteoarthritis, providing pain relief and improved functional outcomes on short-term intervals up to 12 months follow-up. Mesenchymal stem cells display some chondroprotective effects requiring further research and development.https://e-journal.unair.ac.id/JOINTS/article/view/48410hyaluronic acidhuman and medicinemesenchymal stem cellosteoarthritis
spellingShingle I Gusti Ngurah Wien Aryana
Febyan
Shianita Limena
Functional Outcome of Mesenchymal Stem Cells Vs. Hyaluronic Acid in Knee Osteoarthritis Kellgren-Lawrence Grade I-III At 6-and 12-Months Follow-Up: A Meta-Analysis
Journal Orthopaedi and Traumatology Surabaya
hyaluronic acid
human and medicine
mesenchymal stem cell
osteoarthritis
title Functional Outcome of Mesenchymal Stem Cells Vs. Hyaluronic Acid in Knee Osteoarthritis Kellgren-Lawrence Grade I-III At 6-and 12-Months Follow-Up: A Meta-Analysis
title_full Functional Outcome of Mesenchymal Stem Cells Vs. Hyaluronic Acid in Knee Osteoarthritis Kellgren-Lawrence Grade I-III At 6-and 12-Months Follow-Up: A Meta-Analysis
title_fullStr Functional Outcome of Mesenchymal Stem Cells Vs. Hyaluronic Acid in Knee Osteoarthritis Kellgren-Lawrence Grade I-III At 6-and 12-Months Follow-Up: A Meta-Analysis
title_full_unstemmed Functional Outcome of Mesenchymal Stem Cells Vs. Hyaluronic Acid in Knee Osteoarthritis Kellgren-Lawrence Grade I-III At 6-and 12-Months Follow-Up: A Meta-Analysis
title_short Functional Outcome of Mesenchymal Stem Cells Vs. Hyaluronic Acid in Knee Osteoarthritis Kellgren-Lawrence Grade I-III At 6-and 12-Months Follow-Up: A Meta-Analysis
title_sort functional outcome of mesenchymal stem cells vs hyaluronic acid in knee osteoarthritis kellgren lawrence grade i iii at 6 and 12 months follow up a meta analysis
topic hyaluronic acid
human and medicine
mesenchymal stem cell
osteoarthritis
url https://e-journal.unair.ac.id/JOINTS/article/view/48410
work_keys_str_mv AT igustingurahwienaryana functionaloutcomeofmesenchymalstemcellsvshyaluronicacidinkneeosteoarthritiskellgrenlawrencegradeiiiiat6and12monthsfollowupametaanalysis
AT febyan functionaloutcomeofmesenchymalstemcellsvshyaluronicacidinkneeosteoarthritiskellgrenlawrencegradeiiiiat6and12monthsfollowupametaanalysis
AT shianitalimena functionaloutcomeofmesenchymalstemcellsvshyaluronicacidinkneeosteoarthritiskellgrenlawrencegradeiiiiat6and12monthsfollowupametaanalysis